Cargando…

What do we learn from a Genome Wide Association Study performed on HIV-1 infected Long Term Non Progressors individuals?

Detalles Bibliográficos
Autores principales:	Guergnon, Julien, Dalmasso, Cyril, Theodorou, Ioannis, Riva, Agostino
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766982/ http://dx.doi.org/10.1186/1742-4690-6-S2-O27

Ejemplares similares

Drugs for malaria elimination: what do we have now and what do we need?
por: Shanks, Dennis
Publicado: (2014)

Financial incentives for human resources for health: What do we know? What do we do? The case of Sierra Leone
por: Bertone, Maria Paola
Publicado: (2014)

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors
por: Zhang, Mei-Yun, et al.
Publicado: (2006)

0A07-01. HIV-specific CD8(+ )T-cells of vaccinees exhibit proliferative and cytotoxic capacities comparable to those of progressors
por: Rood, JE, et al.
Publicado: (2009)

S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers
por: Descours, B, et al.
Publicado: (2009)

The lateral trauma position – what do we know, how do we use it? A cross-sectional survey of all Norwegian emergency medical services
por: Fattah, S, et al.
Publicado: (2012)

OA09 Challenging case of psoriatic arthritis: what should we do next?
por: Mohareb, Marwa, et al.
Publicado: (2022)

Factors involved in the development of the metabolic syndrome. We are what we eat and what we are eating
por: Masuzaki, Hiroaki
Publicado: (2013)

Inpatient and emergency child and adolescent psychiatry units in Sweden do not use restraint and seclusion: what we have learned
por: Rydelius, Per-Anders
Publicado: (2007)

Are we ready? What is missing and what is needed? A regulator’s perspective
por: Bernardini, Claudia, et al.
Publicado: (2014)

Who do we think we are: interdisciplinary dissonance and the development of professional identity
por: Barbaro-Brown, Judith
Publicado: (2010)

HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point?
por: Gheorghiță, Valeriu, et al.
Publicado: (2014)

We now know what fly photoreceptors compute
por: Friederich, Uwe, et al.
Publicado: (2013)

Congenital myelomeningocele – do we have to change our management?
por: Mayer, Steffi, et al.
Publicado: (2010)

Evaluating new diagnostic tests in the field – are we doing it right?
por: Menzies, Dick
Publicado: (2010)

Do we know the place of systemic corticosteroids in infectious diseases?
por: Hristea, Adriana, et al.
Publicado: (2013)

O031: Reprocessing of single-use hemodynamic catheters in cardiology-we do but how best to do it
por: Rao, R, et al.
Publicado: (2013)

Medical syncretism in Yogyakarta: what do the practitioners get?
por: Padmawati, Retna Siwi, et al.
Publicado: (2014)

OA08 Atypical femoral fracture secondary to long term bisphosphonate use; are we doing enough to prevent it?
por: Raj, Arjun, et al.
Publicado: (2023)

Clinical trials in breast cancer; do we have the right approaches?
por: Lønning, PE
Publicado: (2000)

Complex congenital scoliosis: brace treatment. What can we expect?
por: Kaced, Houria, et al.
Publicado: (2010)

The repaired tetralogy of Fallot become adult: what should we expect
por: Angeli, E, et al.
Publicado: (2013)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

How early to start: what do observational data suggest?
por: Sterne, J
Publicado: (2010)

Oncology update: what do all those acronyms mean?
por: Hughes-Davies, L
Publicado: (2006)

Virus discovery in sandflies, from field studies to phylogenetic tree building: classic methods versus novel methods, what do we need to address public health impact?
por: Bichaud, L, et al.
Publicado: (2014)

A podiatry survey: how do we treat hallux valgus conservatively?
por: Hurn, Sheree, et al.
Publicado: (2015)

Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013)

O078: 6 years of national German hand hygiene campaign-where do we come from and where are we heading to?
por: Reichardt, C, et al.
Publicado: (2013)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Computational chemistry in pharmaceutical research – where do we stand after 25 years?
por: Köppen, Herbert
Publicado: (2012)

Reproducibility in cheminformatics and computational chemistry research: certainly we can do better than this
por: Landrum, Gregory A
Publicado: (2013)

If MIAVR is so good, why aren't we all doing it? A UK perspective
por: Smyth, Justin
Publicado: (2013)

Preferential targeting of co-evolving Gag residues in long-term non progressors
por: Sunshine, J, et al.
Publicado: (2012)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

What affects the bone in our HIV-positive patients?
por: Fux, CA
Publicado: (2010)

The changing face of HIV resistance; HIV drug resistance north and south — what's next?
por: Schapiro, J
Publicado: (2010)

30 years of HIV: what have we learned?
por: Gazzard, Brian
Publicado: (2014)

How do we work with medical teams to provide optimal treatment for clients in the acute medical environment?
por: Stokes, Lisa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mvgdavna4duncic7dva1ocu506